Riskpilot← Back to searchSign inGet full accessKomplementarselskabet Inspicos ApS
APSActiveCVR 37116319Strandvejen 60Other financial service activities, except insurance and pension funding n.e.c. · NACE 6499Est. 2015— employees
Revenue 2025
DKK 1K
-86% vs 2024
EBITDA margin
100.0%
+280% vs 2024
Equity ratio
82.9%
Financial strength
Net profit 2025
DKK 576
+148% vs 2024
| Revenue | DKK 1K | -86% |
| EBITDA | DKK 1K | +280% |
| Net profit | DKK 576 | +148% |
| Total assets | DKK 52K | +2% |
| Equity | DKK 43K | +1% |
| Employees | — | — |
Legal name
Komplementarselskabet Inspicos ApS
CVR number
37116319
Legal form
Anpartsselskab
NACE code
6499 · Other financial service activities, except insurance and pension funding n.e.c.
Founded
25. september 2015
Share capital
DKK 44.444
Employees
—
VAT registered
No
Audit selected
Yes
Last report
2025-09-30
Financial year
January – December
Signatory rights
Selskabet tegnes af den samlede bestyrelse, af to bestyrelsesmedlemmer i forening eller af den administrerende direktør i forening med et bestyrelsesmedlem.
Company purpose
Selskabets formål er at være komplementar i Inspicos P/S og at administrere Inspicos P/S.
Address
Strandvejen 60
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -6 | -10 | -7 | 15 | 15 | 15 | 14 | 8 | 8 | 1 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -6 | -10 | -7 | 8 | 7 | 8 | 6 | -0 | -1 | 1 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -6 | -10 | -7 | 8 | 7 | 8 | 6 | -0 | -1 | 1 |
| Net financials | 0 | -0 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -0 |
| Profit before tax | -6 | -10 | -8 | 7 | 6 | 7 | 5 | -1 | -2 | 1 |
| Tax | -1 | -2 | -2 | 1 | 1 | 1 | 1 | -0 | -0 | 0 |
| Net profit | -5 | -8 | -6 | 5 | 5 | 5 | 4 | -1 | -1 | 1 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 51 | 44 | 54 | 52 | 50 | 54 | 58 | 58 | 51 | 52 |
| Equity | 45 | 37 | 31 | 36 | 41 | 46 | 50 | 49 | 42 | 43 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 7 | 7 | 23 | 16 | 9 | 8 | 8 | 8 | 9 | 9 |
| Total debt | 7 | 7 | 23 | 16 | 9 | 8 | 8 | 8 | 9 | 9 |
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
20162025
Equity ratio
82.9%
This company
38.2%
Market median
+117% vs market
20162025
Return on equity
1.3%
This company
18.4%
Market median
-93% vs market
20162025
Net profit margin
51.2%
This company
8.1%
Market median
+532% vs market
20162025
Asset turnover
0.02×
This company
1.12×
Market median
-98% vs market
20162025
Debt / equity
0.21×
This company
0.62×
Market median
+66% vs market
20162025
- Annual report 2025Filed via CVR / Virk · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via CVR / Virk · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via CVR / Virk · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via CVR / Virk · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via CVR / Virk · Period 2020-10-01 – 2021-09-30
- Annual report 2020Filed via CVR / Virk · Period 2019-10-01 – 2020-09-30
- Annual report 2019Filed via CVR / Virk · Period 2018-10-01 – 2019-09-30
- Annual report 2018Filed via CVR / Virk · Period 2017-10-01 – 2018-09-30
- Annual report 2017Filed via CVR / Virk · Period 2016-10-01 – 2017-09-30
- Annual report 2016Filed via CVR / Virk · Period 2015-09-25 – 2016-09-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JP Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2015 | — | — | |
| Board of Directors | 2017 | — | — | |
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2017 | — | — | |
| Board of Directors | 2017 | — | — | |
| Board of Directors | 2015 | — | — | |
| Board of Directors | 2017 | — | — | |
| Board of Directors | 2017 | — | — | |
| Board of Directors | 2015 | — | — | |
| Chairman | 2015 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Ipras JPF ApS | Company | 10.0% | 10.0% | 2015 |
Ipras STM ApS | Company | 10.0% | 10.0% | 2015 |
Ipras CLT ApS | Company | 10.0% | 10.0% | 2015 |
Ipras PEH ApS | Company | 10.0% | 10.0% | 2015 |
Ipras JS ApS | Company | 10.0% | 10.0% | 2015 |
IPRAS ALO ApS | Company | 10.0% | 10.0% | 2016 |
Ipras PKO ApS | Company | 10.0% | 10.0% | 2015 |
Ipras PS ApS | Company | 10.0% | 10.0% | 2015 |
Ipras JT ApS | Company | 10.0% | 10.0% | 2015 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
PETER KOEFOED PATENTS ApS
Komplementarselskabet Inspicos ApS Board members of Komplementarselskabet Inspicos ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jakob Pade Frederiksen | Chief Executive Officer | 0 companies |
| Jan Lyngberg Simonsen | Board of Directors | 0 companies |
| Peter Hertling | Board of Directors | 0 companies |
| Edward John Farrington | Board of Directors | 0 companies |
| Peter Koefoed | Board of Directors | 0 companies |
| Pia Marianne Stahr | Board of Directors | 0 companies |
| Jesper Thorsen | Board of Directors | 0 companies |
| Anna Viktoria Lövqvist | Board of Directors | 0 companies |
| Ulla Klinge | Board of Directors | 0 companies |
| Steen Madsen | Board of Directors | 0 companies |
| Christa Larsen Theil | Chairman | 0 companies |